RT Journal Article
SR Electronic
T1 Development of a clinical risk score to risk stratify for a serious cause of vertigo: A prospective cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.03.04.24303562
DO 10.1101/2024.03.04.24303562
A1 Ohle, Robert
A1 Savage, David W.
A1 Roy, Danielle
A1 McIsaac, Sarah
A1 Singh, Ravinder
A1 Lelli, Daniel
A1 Tse, Darren
A1 Johns, Peter
A1 Yadav, Krishan
A1 Perry, Jeffrey J.
YR 2024
UL http://medrxiv.org/content/early/2024/03/04/2024.03.04.24303562.abstract
AB Objectives Identify high-risk clinical characteristics for a serious cause of vertigo in patients presenting to the emergency department.Design Multicentre prospective cohort study over 3 years.Setting Three university-affiliated tertiary care emergency departments.Participants Patients presenting with vertigo, dizziness or imbalance. A total of 2078 of 2618 potentially eligible patients (79.4%) were enrolled (mean age 77.1 years; 59% women).Main outcome measurements An adjudicated serious diagnosis defined as stroke, transient ischemic attack, vertebral artery dissection or brain tumour.Results Serious events occurred in 111 (5.3%) patients. We used logistic regression to create a 7-item prediction model: male, age over 65, hypertension, diabetes, motor/sensory deficits, cerebellar signs/symptoms and benign paroxysmal positional vertigo diagnosis (C-statistic 0.96, 95% confidence interval [CI] 0.92–0.98). The risk of a serious diagnosis ranged from 0% for a score of <5, 2.1% for a score of 5-8, and 41% for a score >8. Sensitivity for a serious diagnosis was 100% (95% CI, 97.1-100%) and specificity 72.1% (95% CI, 70.1-74%) for a score <5.Conclusions The Sudbury Vertigo Risk Score identifies the risk of a serious diagnosis as a cause of a patient’s vertigo and can assist physicians in guiding further investigation, consultation and treatment decisions, improving resource utilization and reducing missed diagnoses.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPhysician Services Incorporated, NOAMAAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Health Sciecnes North Institutional Ethics BoardI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAvailable on request